Navigation Links
ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006
Date:2/13/2008

CHARLES TOWN, W.V., Feb. 13 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), developers of state of the art electronic devices for diabetic peripheral neuropathy, Molluscum Contagiosum, and MRSA, announces 2007 sales up 89% over last year, details are available on their Annual Report on http://www.pinksheets.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

"The company's growth has continued upward despite the nation's concerns about economic recession and the weakening dollar. We expect to maintain that stable growth pattern in 2008 based upon several factors 1) we manufacture and sell our own products, 2) our products are medical in nature and are essential to our customers, representing a less expensive while more effective alternative to traditional therapies, 3) we have a strong overseas market for our products, where consumers are anxious to buy U.S. products with their stronger currencies" states David Phillips, Ph.D., CEO of RBRM. RBRM's annual shareholder meeting is scheduled for 3pm on February 14, 2008.

For more information visit: http://www.rebuildermedical.com, http://www.molluscum.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.


'/>"/>
SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
2. ReBuilder Medical Technologies, Inc. Announces Televised Broadcast
3. ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
4. ReBuilder Medical Technologies, Inc. Reports Doubled Profits for October
5. ReBuilder Medical Technologies, Inc. Announces Record Sales Month
6. ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment
7. ReBuilder Medical Technologies, Inc. Hires Nurses Exclusively to Provide Customer Support
8. ReBuilder Medical Technologies, Inc. Increases Manufacturing Space to Meet Demand
9. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
10. ReBuilder Medical Technologies, Inc. Announces Agreement with Internet Marketer Helio Health; Anticipates 12% Additional Profit
11. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... TX (PRWEB) , ... January 19, 2017 , ... Attorney ... for the fifth consecutive year donated money to the Triumph Over Kid Cancer foundation. ... Ragan was one of those children. James saw firsthand the effect of the critical ...
(Date:1/19/2017)... ... ... The CHP suggests that California drivers can avoid hydroplaning as well as ... the space between themselves and other vehicles, according to a January 3 article ... notes that, rain or shine, drivers should always incorporate safe driving practices in their ...
(Date:1/19/2017)... ... January 19, 2017 , ... The 21st Century Cures Act’s Impact ... Webinar**, Jan. 26, 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          ... Act in order to thrive this year? , The passage of the act means ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Infinity® Massage ... business plan and implement new sales and marketing strategies. Grover comes with a total ... last 5 and a half years as Executive Vice President of Direct Sales at ...
(Date:1/19/2017)... ... January 19, 2017 , ... Fillers are known for building ... know that popular cosmetic fillers can enhance earlobes and rejuvenate an ... of the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. “People ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 18, 2017 The Global ... understanding and access to partnering deals and agreements entered ... Trends in partnering deals - Top deals by value ... of development, technology type The report provides understanding ... into by the world,s leading healthcare companies. The ...
(Date:1/19/2017)... , Jan. 18, 2017 The Academy ... and Drug Administration (FDA) for its release today ... population health decision makers can proactively share clinical ... as well as emerging therapies awaiting FDA approval. ... consensus recommendations that AMCP developed during two multi-stakeholder ...
(Date:1/18/2017)... PORTLAND, Oregon and PUNE, India ... report published by Allied Market Research, titled, "Breast Imaging Technologies ... projects that the global breast imaging technologies market size was ... reach $4,502 million by 2022, growing at a CAGR of ... and Europe together accounted for ...
Breaking Medicine Technology: